Browse by Changes
Summary of Changes – 1 July 2014
Previous versions of the Summary of Changes are available in PDF in the Publications Archive.
- Additions
- Deletions
- Alterations
- Advance Notices
- Section 100 – Highly Specialised Drugs Program
- Section 100 – Efficient Funding of Chemotherapy
- Repatriation Schedule of Pharmaceutical Benefits (RPBS)
Addition – Item
| 10107Y | Bimatoprost + Timolol, bimatoprost 0.03% + timolol 0.5% eye drops, 30 x 0.4 mL unit doses (GANfort PF 0.3/5) |
| 10108B | Bimatoprost + Timolol, bimatoprost 0.03% + timolol 0.5% eye drops, 30 x 0.4 mL unit doses (GANfort PF 0.3/5) |
Addition – Brand
| 9314F | Adesan HCT 32/12.5, AF – Candesartan + Hydrochlorothiazide, candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 9315G | Adesan HCT 32/25, AF – Candesartan + Hydrochlorothiazide, candesartan cilexetil 32 mg + hydrochlorothiazide 25 mg tablet, 30 |
| 8315P | Cefepime Alphapharm, AF – Cefepime, CEFEPIME Powder for injection 1 g (as hydrochloride), 1 |
| 8316Q | Cefepime Alphapharm, AF – Cefepime, CEFEPIME Powder for injection 2 g (as hydrochloride), 1 |
| 8318T | Clarihexal, HX – Clarithromycin, clarithromycin 250 mg tablet, 14 |
| 8063J | Lamotrigine Aspen 5, FM – Lamotrigine, lamotrigine 5 mg tablet, 56 |
| 5552F | Latanoprost GH, GQ – Latanoprost, latanoprost 0.005% eye drops, 2.5 mL |
| 8243W | Latanoprost GH, GQ – Latanoprost, latanoprost 0.005% eye drops, 2.5 mL |
| 5553G | APO-Latanoprost/Timolol 0.05/5, TX – Latanoprost + Timolol, latanoprost 0.005% + timolol 0.5% eye drops, 2.5 mL |
| 8895E | APO-Latanoprost/Timolol 0.05/5, TX – Latanoprost + Timolol, latanoprost 0.005% + timolol 0.5% eye drops, 2.5 mL |
| 9306T | APO-Memantine, TX – Memantine, memantine hydrochloride 20 mg tablet, 28 |
| 2513G | APO-Memantine, TX – Memantine, memantine hydrochloride 20 mg tablet, 28 |
| 8855C | Mirtazapine Sandoz ODT 15, SZ – Mirtazapine, MIRTAZAPINE Tablet 15 mg (orally disintegrating), 30 |
| 8856D | Mirtazapine Sandoz ODT 30, SZ – Mirtazapine, MIRTAZAPINE Tablet 30 mg (orally disintegrating), 30 |
| 8857E | Mirtazapine Sandoz ODT 45, SZ – Mirtazapine, MIRTAZAPINE Tablet 45 mg (orally disintegrating), 30 |
| 8007K | Pantoprazole Actavis, GN – Pantoprazole, pantoprazole 40 mg tablet: enteric, 30 |
| 8008L | Pantoprazole Actavis, GN – Pantoprazole, pantoprazole 40 mg tablet: enteric, 30 |
| 3403D | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 10 mg tablet, 30 |
| 9043Y | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 10 mg tablet, 30 |
| 2584B | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 10 mg tablet, 30 |
| 2628H | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 10 mg tablet, 30 |
| 3404E | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 20 mg tablet, 30 |
| 9044B | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 20 mg tablet, 30 |
| 2609H | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 20 mg tablet, 30 |
| 2574L | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 20 mg tablet, 30 |
| 3405F | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 40 mg tablet, 30 |
| 9045C | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 40 mg tablet, 30 |
| 2636R | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 40 mg tablet, 30 |
| 2594M | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 40 mg tablet, 30 |
| 3402C | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 5 mg tablet, 30 |
| 9042X | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 5 mg tablet, 30 |
| 2590H | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 5 mg tablet, 30 |
| 2606E | Rosuvastatin-DRLA, RI – Rosuvastatin, rosuvastatin 5 mg tablet, 30 |
| 8144P | Sumatran, QA – Sumatriptan, SUMATRIPTAN Tablet 50 mg (as succinate), 2 |
| 1849H | Sumatran, QA – Sumatriptan, sumatriptan 50 mg tablet, 4 |
| 8979N | Pritor/Amlodipine, FI – Telmisartan + Amlodipine, telmisartan 40 mg + amlodipine 10 mg tablet, 28 |
| 8978M | Pritor/Amlodipine, FI – Telmisartan + Amlodipine, telmisartan 40 mg + amlodipine 5 mg tablet, 28 |
| 8981Q | Pritor/Amlodipine, FI – Telmisartan + Amlodipine, telmisartan 80 mg + amlodipine 10 mg tablet, 28 |
| 8980P | Pritor/Amlodipine, FI – Telmisartan + Amlodipine, telmisartan 80 mg + amlodipine 5 mg tablet, 28 |
Addition – Equivalence Indicator
| 2513G | Ebixa, LU – Memantine, memantine hydrochloride 20 mg tablet, 28 |
| 9306T | Ebixa, LU – Memantine, memantine hydrochloride 20 mg tablet, 28 |
| 8979N | Twynsta, BY – Telmisartan + Amlodipine, telmisartan 40 mg + amlodipine 10 mg tablet, 28 |
| 8978M | Twynsta, BY – Telmisartan + Amlodipine, telmisartan 40 mg + amlodipine 5 mg tablet, 28 |
| 8981Q | Twynsta, BY – Telmisartan + Amlodipine, telmisartan 80 mg + amlodipine 10 mg tablet, 28 |
| 8980P | Twynsta, BY – Telmisartan + Amlodipine, telmisartan 80 mg + amlodipine 5 mg tablet, 28 |
Addition – Restriction
| 2868Y | Ivermectin, ivermectin 3 mg tablet, 4 (Stromectol) |
Deletion – Item
| 9198D | Nicotine, NICOTINE Transdermal patch releasing approximately 15 mg per 16 hours, 28 (Nicorette Patch) |
Deletion – Brand
| 1208N | Cifran, RA – Ciprofloxacin, ciprofloxacin 250 mg tablet, 14 |
| 1335G | Coras, AF – Diltiazem, diltiazem hydrochloride 60 mg tablet, 90 |
| 5082L | Doxyhexal, SZ – Doxycycline, doxycycline 100 mg tablet, 7 |
| 9105F | Doxyhexal, SZ – Doxycycline, doxycycline 100 mg tablet, 7 |
| 9107H | Doxyhexal, SZ – Doxycycline, doxycycline 100 mg tablet, 7 |
| 9108J | Doxyhexal, SZ – Doxycycline, doxycycline 100 mg tablet, 7 |
| 9106G | Doxyhexal, SZ – Doxycycline, doxycycline 50 mg tablet, 25 |
| 8400D | Hyforil, RA – Fosinopril + Hydrochlorothiazide, fosinopril sodium 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 8401E | Hyforil, RA – Fosinopril + Hydrochlorothiazide, fosinopril sodium 20 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 2245E | Fresenius Kabi Australia Pty Limited, PK – Glucose, glucose 5% (50 g/1000 mL) injection, 1 x 1000 mL bag |
| 5106R | Fresenius Kabi Australia Pty Limited, PK – Glucose, glucose 5% (50 g/1000 mL) injection, 1 x 1000 mL bag |
| 2286H | Fresenius Kabi Australia Pty Limited, PK – Lactate + Sodium Chloride + Potassium Chloride + Calcium Chloride Dihydrate, lactate sodium 0.322% (3.22 g/1000 mL) + sodium chloride 0.6% (6 g/1000 mL) + potassium chloride 0.04% (400 mg/1000 mL) + calcium chloride dihydrate 0.027% (270 mg/1000 mL) injection, 1 x 1000 mL bag |
| 8457D | Quipine, VN – Quetiapine, quetiapine 100 mg tablet, 90 |
| 8458E | Quipine, VN – Quetiapine, quetiapine 200 mg tablet, 60 |
| 8456C | Quipine, VN – Quetiapine, quetiapine 25 mg tablet, 60 |
| 8580N | Quipine, VN – Quetiapine, quetiapine 300 mg tablet, 60 |
| 9242K | Simvastatin-Spirit 10, ZP – Simvastatin, simvastatin 10 mg tablet, 30 |
| 2011W | Simvastatin-Spirit 10, ZP – Simvastatin, simvastatin 10 mg tablet, 30 |
| 9243L | Simvastatin-Spirit 20, ZP – Simvastatin, simvastatin 20 mg tablet, 30 |
| 2012X | Simvastatin-Spirit 20, ZP – Simvastatin, simvastatin 20 mg tablet, 30 |
| 8173E | Simvastatin-Spirit 40, ZP – Simvastatin, simvastatin 40 mg tablet, 30 |
| 9244M | Simvastatin-Spirit 40, ZP – Simvastatin, simvastatin 40 mg tablet, 30 |
| 8313M | Simvastatin-Spirit 80, ZP – Simvastatin, simvastatin 80 mg tablet, 30 |
| 9245N | Simvastatin-Spirit 80, ZP – Simvastatin, simvastatin 80 mg tablet, 30 |
| 2264E | Fresenius Kabi Australia Pty Limited, PK – Sodium Chloride, sodium chloride 0.9% (9 g/1000 mL) injection, 1 x 1000 mL bag |
| 5212H | Fresenius Kabi Australia Pty Limited, PK – Sodium Chloride, sodium chloride 0.9% (9 g/1000 mL) injection, 1 x 1000 mL bag |
| 5232J | Lodam 50, ZP – Tramadol, tramadol hydrochloride 50 mg capsule, 20 |
| 8455B | Lodam 50, ZP – Tramadol, tramadol hydrochloride 50 mg capsule, 20 |
| 8611F | Lodam 50, ZP – Tramadol, tramadol hydrochloride 50 mg capsule, 20 |
Alteration – Brand Name
| From: | |
| 10002K | Atozet Composite Pack 10mg + 10mg, MK – Atorvastatin (&) Ezetimibe, atorvastatin 10 mg tablet [30] (&) ezetimibe 10 mg tablet [30], 1 pack |
| To: | |
| 10002K | Atozet Composite Pack, MK – Atorvastatin (&) Ezetimibe, atorvastatin 10 mg tablet [30] (&) ezetimibe 10 mg tablet [30], 1 pack |
| From: | |
| 2874G | Atozet Composite Pack 10mg + 20mg, MK – Atorvastatin (&) Ezetimibe, atorvastatin 20 mg tablet [30] (&) ezetimibe 10 mg tablet [30], 1 pack |
| To: | |
| 2874G | Atozet Composite Pack, MK – Atorvastatin (&) Ezetimibe, atorvastatin 20 mg tablet [30] (&) ezetimibe 10 mg tablet [30], 1 pack |
| From: | |
| 2821L | Atozet Composite Pack 10mg +40mg, MK – Atorvastatin (&) Ezetimibe, atorvastatin 40 mg tablet [30] (&) ezetimibe 10 mg tablet [30], 1 pack |
| To: | |
| 2821L | Atozet Composite Pack, MK – Atorvastatin (&) Ezetimibe, atorvastatin 40 mg tablet [30] (&) ezetimibe 10 mg tablet [30], 1 pack |
| From: | |
| 10006P | Atozet Composite Pack 10mg + 80mg, MK – Atorvastatin (&) Ezetimibe, atorvastatin 80 mg tablet [30] (&) ezetimibe 10 mg tablet [30], 1 pack |
| To: | |
| 10006P | Atozet Composite Pack, MK – Atorvastatin (&) Ezetimibe, atorvastatin 80 mg tablet [30] (&) ezetimibe 10 mg tablet [30], 1 pack |
Alteration – Restriction
Note: Items which are Streamlined drugs have had a code change.
| 5290K | Eletriptan, eletriptan 40 mg tablet, 4 (Relpax) |
| 5291L | Eletriptan, eletriptan 80 mg tablet, 4 (Relpax) |
| 8298R | Naratriptan, naratriptan 2.5 mg tablet, 2 (Naramig) |
| 9313E | Rizatriptan, rizatriptan 10 mg wafer, 2 (Maxalt) |
| 8341B | Sumatriptan, sumatriptan 20 mg/actuation nasal spray, 2 actuations (Imigran) |
| 8885P | Sumatriptan, SUMATRIPTAN Tablet (fast disintegrating) 50 mg (as succinate), 2 (Imigran FDT) |
| 8144P | Sumatriptan, SUMATRIPTAN Tablet 50 mg (as succinate), 2 (APO-Sumatriptan, Chem mart Sumatriptan, Imigran, Sumagran Aspen 50, Sumatab, Sumatran, Sumatriptan Sandoz, Terry White Chemists Sumatriptan) |
| 1849H | Sumatriptan, sumatriptan 50 mg tablet, 4 (APO-Sumatriptan, Chem mart Sumatriptan, Pharmacor Sumatriptan 50, Sumatran, Sumatriptan-GA, Sumatriptan generichealth, Sumatriptan RBX, Sumatriptan Sandoz, Terry White Chemists Sumatriptan) |
Alteration – Authority required to Authority required (STREAMLINED)
| 8266C | Zolmitriptan, zolmitriptan 2.5 mg tablet, 2 (Zoltrip, Zomig) |
Alteration – Manufacturer's Code
| From: | To: | ||
|---|---|---|---|
| 2019G | Neotigason, UA – Acitretin, acitretin 10 mg capsule, 100 | TA | UA |
| 2020H | Neotigason, UA – Acitretin, acitretin 25 mg capsule, 100 | TA | UA |
| 9354H | Clopidogrel Actavis, UA – Clopidogrel, clopidogrel 75 mg tablet, 28 | TA | UA |
| 2501P | Lofenoxal, IA – Diphenoxylate + Atropine Sulfate, diphenoxylate hydrochloride 2.5 mg + atropine sulfate 25 microgram tablet, 20 | HC | IA |
| 2501P | Lomotil, IV – Diphenoxylate + Atropine Sulfate, diphenoxylate hydrochloride 2.5 mg + atropine sulfate 25 microgram tablet, 20 | BI | IV |
| 2848X | Torlemo DT 25, UA – Lamotrigine, lamotrigine 25 mg tablet, 56 | TA | UA |
| 2849Y | Torlemo DT 50, UA – Lamotrigine, lamotrigine 50 mg tablet, 56 | TA | UA |
| 2850B | Torlemo DT 100, UA – Lamotrigine, lamotrigine 100 mg tablet, 56 | TA | UA |
| 2851C | Torlemo DT 200, UA – Lamotrigine, lamotrigine 200 mg tablet, 56 | TA | UA |
| 8245Y | Letrozole Actavis, VN – Letrozole, letrozole 2.5 mg tablet, 30 | TA | VN |
| 8399C | Torzole 20, VN – Pantoprazole, pantoprazole 20 mg tablet: enteric, 30 tablets | TA | VN |
| 8007K | Torzole 40, VN – Pantoprazole, pantoprazole 40 mg tablet: enteric, 30 | TA | VN |
| 8008L | Torzole 40, VN – Pantoprazole, pantoprazole 40 mg tablet: enteric, 30 | TA | VN |
| 2833D | Pravastatin Actavis 10, UA – Pravastatin, pravastatin sodium 10 mg tablet, 30 | TA | UA |
| 9237E | Pravastatin Actavis 10, UA – Pravastatin, pravastatin sodium 10 mg tablet, 30 | TA | UA |
| 2834E | Pravastatin Actavis 20, UA – Pravastatin, pravastatin sodium 20 mg tablet, 30 | TA | UA |
| 9238F | Pravastatin Actavis 20, UA – Pravastatin, pravastatin sodium 20 mg tablet, 30 | TA | UA |
| 8197K | Pravastatin Actavis 40, UA – Pravastatin, pravastatin sodium 40 mg tablet, 30 | TA | UA |
| 9239G | Pravastatin Actavis 40, UA – Pravastatin, pravastatin sodium 40 mg tablet, 30 | TA | UA |
| 8456C | Quetiapine Actavis 25, VN – Quetiapine, quetiapine 25 mg tablet, 60 | TA | VN |
| 8457D | Quetiapine Actavis 100, VN – Quetiapine, quetiapine 100 mg tablet, 90 | TA | VN |
| 8458E | Quetiapine Actavis 200, VN – Quetiapine, quetiapine 200 mg tablet, 60 | TA | VN |
| 8580N | Quetiapine Actavis 300, VN – Quetiapine, quetiapine 300 mg tablet, 60 | TA | VN |
| 8253J | Rapilysin 10 U, GN – Reteplase, reteplase 10 units (17.4 mg) injection [2 x 10 units vials] (&) inert substance diluent [2 x 10 mL syringes], 1 pack | TA | GN |
Advance Notices – Deletion of Item
The following items will be deleted from the Schedule of Pharmaceutical Benefits on 1 September 2014:
| 5005K | Fresenius Kabi Australia Pty Limited, PK – Glucose, glucose 5% (25 g/500 mL) injection, 1 x 500 mL bag |
| 9444C | Fresenius Kabi Australia Pty Limited, PK – Glucose, glucose 5% (25 g/500 mL) injection, 1 x 500 mL bag |
| 9445D | Fresenius Kabi Australia Pty Limited, PK – Glucose, glucose 10% (50 g/500 mL) injection, 1 x 500 mL bag |
| 9474P | Glucose 5% Freeflex, PK – Glucose, glucose 5% (12.5 g/250 mL) injection, 1 x 250 mL bag |
| 9416N | Fresenius Kabi Australia Pty Limited, PK – Lactate + Sodium Chloride + Potassium Chloride + Calcium Chloride Dihydrate, lactate sodium 0.322% (1.61 g/500 mL) + sodium chloride 0.6% (3 g/500 mL) + potassium chloride 0.04% (200 mg/500 mL) + calcium chloride dihydrate 0.027% (135 mg/500 mL) injection, 1 x 500 mL bag |
| 8272J | Probitor Hp7, SZ – Omeprazole (&) Clarithromycin (&) Amoxycillin, omeprazole 20 mg capsule [14 capsules] (&) clarithromycin 500 mg tablet [14 tablets] (&) amoxycillin 500 mg capsule [28 capsules], 1 pack |
| 9392H | Fresenius Kabi Australia Pty Limited, PK – Sodium Chloride, sodium chloride 0.9% (4.5 g/500 mL) injection, 1 x 500 mL bag |
| 9473N | Sodium Chloride 0.9% Freeflex, PK – Sodium Chloride, sodium chloride 0.9% (2.25 g/250 mL) injection, 1 x 250 mL bag |
| 5021G | Fresenius Kabi Australia Pty Limited, PK – Sodium Chloride, sodium chloride 0.9% (4.5 g/500 mL) injection, 1 x 500 mL bag |
| 8098F | Merck Sharp & Dohme (Australia) Pty Ltd, MK – Testosterone, testosterone 100 mg implant, 1 |
| 8099G | Merck Sharp & Dohme (Australia) Pty Ltd, MK – Testosterone, testosterone 200 mg implant, 1 |
Advance Notices – Deletion of Brand
The following brand will be deleted from the Schedule of Pharmaceutical Benefits on 1 August 2014:
| 1967M | Locilan 28 Day, FZ – Norethisterone, norethisterone 350 microgram tablet, 112 [4 x 28] |
Section 100 – Highly Specialised Drugs Program
Alteration – Number of Repeats
| From | To |
||
|---|---|---|---|
| 5777C | Lanreotide, lanreotide 60 mg injection, 1 syringe (Somatuline Autogel) (Public) | 11 | 5 |
| 6423C | Lanreotide, lanreotide 60 mg injection, 1 syringe (Somatuline Autogel) (Private) | 11 | 5 |
| 5778D | Lanreotide, lanreotide 90 mg injection, 1 syringe (Somatuline Autogel) (Public) | 11 | 5 |
| 6424D | Lanreotide, lanreotide 90 mg injection, 1 syringe (Somatuline Autogel) (Private) | 11 | 5 |
| 5779E | Lanreotide, lanreotide 120 mg injection, 1 syringe (Somatuline Autogel) (Public) | 11 | 5 |
| 6425E | Lanreotide, lanreotide 120 mg injection, 1 syringe (Somatuline Autogel) (Private) | 11 | 5 |
| 9511N | Octreotide, octreotide 10 mg injection: modified release [1 x 10 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Public) | 11 | 5 |
| 6426F | Octreotide, octreotide 10 mg injection: modified release [1 x 10 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Private) | 11 | 5 |
| 9512P | Octreotide, octreotide 20 mg injection: modified release [1 x 20 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Public) | 11 | 5 |
| 6427G | Octreotide, octreotide 20 mg injection: modified release [1 x 20 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Private) | 11 | 5 |
| 9513Q | Octreotide, octreotide 30 mg injection: modified release [1 x 30 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Public) | 11 | 5 |
| 6428H | Octreotide, octreotide 30 mg injection: modified release [1 x 30 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Private) | 11 | 5 |
Alteration – Maximum Quantity
| From |
To |
||
|---|---|---|---|
| 9511N | Octreotide, octreotide 10 mg injection: modified release [1 x 10 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Public) | 1 | 2 |
| 6426F | Octreotide, octreotide 10 mg injection: modified release [1 x 10 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Private) | 1 | 2 |
| 9512P | Octreotide, octreotide 20 mg injection: modified release [1 x 20 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Public) | 1 | 2 |
| 6427G | Octreotide, octreotide 20 mg injection: modified release [1 x 20 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Private) | 1 | 2 |
| 9513Q | Octreotide, octreotide 30 mg injection: modified release [1 x 30 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Public) | 1 | 2 |
| 6428H | Octreotide, octreotide 30 mg injection: modified release [1 x 30 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Private) | 1 | 2 |
Alteration – Restriction
Note: Items which are Streamlined drugs have had a code change.
| 5777C | Lanreotide, lanreotide 60 mg injection, 1 syringe (Somatuline Autogel) (Public)(Streamlined) |
| 6423C | Lanreotide, lanreotide 60 mg injection, 1 syringe (Somatuline Autogel) (Private) |
| 5778D | Lanreotide, lanreotide 90 mg injection, 1 syringe (Somatuline Autogel) (Public)(Streamlined) |
| 6424D | Lanreotide, lanreotide 90 mg injection, 1 syringe (Somatuline Autogel) (Private) |
| 5779E | Lanreotide, lanreotide 120 mg injection, 1 syringe (Somatuline Autogel) (Public)(Streamlined) |
| 6425E | Lanreotide, lanreotide 120 mg injection, 1 syringe (Somatuline Autogel) (Private) |
| 5776B | Lanreotide, lanreotide 30 mg injection: modified release [1 x 30 mg vial] (&) inert substance diluent [1 x 2 mL ampoule], 1 pack (Somatuline LA) (Public)(Streamlined) |
| 6332G | Lanreotide, lanreotide 30 mg injection: modified release [1 x 30 mg vial] (&) inert substance diluent [1 x 2 mL ampoule], 1 pack (Somatuline LA) (Private) |
| 9511N | Octreotide, octreotide 10 mg injection: modified release [1 x 10 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Public)(Streamlined) |
| 6426F | Octreotide, octreotide 10 mg injection: modified release [1 x 10 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Private) |
| 9512P | Octreotide, octreotide 20 mg injection: modified release [1 x 20 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Public)(Streamlined) |
| 6427G | Octreotide, octreotide 20 mg injection: modified release [1 x 20 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Private) |
| 9513Q | Octreotide, octreotide 30 mg injection: modified release [1 x 30 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Public)(Streamlined) |
| 6428H | Octreotide, octreotide 30 mg injection: modified release [1 x 30 mg vial] (&) inert substance diluent [1 x 2.5 mL syringe], 1 pack (Sandostatin LAR) (Private) |
Advance Notices – Deletion of Item
The following items will be deleted from the Schedule of Pharmaceutical Benefits on 1 September 2014:
| 5821J | Prezista, JC – Darunavir, darunavir 400 mg tablet, 60 (Public) |
| 5823L | Prezista, JC – Darunavir, darunavir 400 mg tablet, 60 (Private) |
Section 100 – Efficient Funding of Chemotherapy
Deletion – Brand
| 7281F | Oncotaxel 20, TA – Docetaxel, docetaxel 20 mg/mL injection, 1 x 1 mL vial |
| 7282G | Oncotaxel 20, TA – Docetaxel, docetaxel 20 mg/mL injection, 1 x 1 mL vial |
| 7283H | Oncotaxel 20, TA – Docetaxel, docetaxel 20 mg/mL injection, 1 x 1 mL vial |
| 7284J | Oncotaxel 20, TA – Docetaxel, docetaxel 20 mg/mL injection, 1 x 1 mL vial |
| 7285K | Oncotaxel 20, TA – Docetaxel, docetaxel 20 mg/mL injection, 1 x 1 mL vial |
| 5581R | Oncotaxel 20, TA – Docetaxel, docetaxel 20 mg/mL injection, 1 x 1 mL vial |
| 5582T | Oncotaxel 20, TA – Docetaxel, docetaxel 20 mg/mL injection, 1 x 1 mL vial |
| 5583W | Oncotaxel 20, TA – Docetaxel, docetaxel 20 mg/mL injection, 1 x 1 mL vial |
| 5584X | Oncotaxel 20, TA – Docetaxel, docetaxel 20 mg/mL injection, 1 x 1 mL vial |
| 5585Y | Oncotaxel 20, TA – Docetaxel, docetaxel 20 mg/mL injection, 1 x 1 mL vial |
| 7249M | Irinotecan Actavis, TA – Irinotecan, irinotecan hydrochloride trihydrate 40 mg/2 mL injection, 1 x 2 mL vial |
| 4451G | Irinotecan Actavis, TA – Irinotecan, irinotecan hydrochloride trihydrate 40 mg/2 mL injection, 1 x 2 mL vial |
Alteration – Manufacturer's Code
| From | To |
||
|---|---|---|---|
| 7281F | Oncotaxel 80, GN – Docetaxel, docetaxel 80 mg/4 mL injection, 1 x 4 mL vial | TA | GN |
| Oncotaxel 140, GN – Docetaxel, docetaxel 140 mg/7 mL injection, 1 x 7 mL vial | TA | GN | |
| 7282G | Oncotaxel 80, GN – Docetaxel, docetaxel 80 mg/4 mL injection, 1 x 4 mL vial | TA | GN |
| Oncotaxel 140, GN – Docetaxel, docetaxel 140 mg/7 mL injection, 1 x 7 mL vial | TA | GN | |
| 7283H | Oncotaxel 80, GN – Docetaxel, docetaxel 80 mg/4 mL injection, 1 x 4 mL vial | TA | GN |
| Oncotaxel 140, GN – Docetaxel, docetaxel 140 mg/7 mL injection, 1 x 7 mL vial | TA | GN | |
| 7284J | Oncotaxel 80, GN – Docetaxel, docetaxel 80 mg/4 mL injection, 1 x 4 mL vial | TA | GN |
| Oncotaxel 140, GN – Docetaxel, docetaxel 140 mg/7 mL injection, 1 x 7 mL vial | TA | GN | |
| 7285K | Oncotaxel 80, GN – Docetaxel, docetaxel 80 mg/4 mL injection, 1 x 4 mL vial | TA | GN |
| Oncotaxel 140, GN – Docetaxel, docetaxel 140 mg/7 mL injection, 1 x 7 mL vial | TA | GN | |
| 5585Y | Oncotaxel 80, GN – Docetaxel, docetaxel 80 mg/4 mL injection, 1 x 4 mL vial | TA | GN |
| Oncotaxel 140, GN – Docetaxel, docetaxel 140 mg/7 mL injection, 1 x 7 mL vial | TA | GN | |
| 5581R | Oncotaxel 80, GN – Docetaxel, docetaxel 80 mg/4 mL injection, 1 x 4 mL vial | TA | GN |
| Oncotaxel 140, GN – Docetaxel, docetaxel 140 mg/7 mL injection, 1 x 7 mL vial | TA | GN | |
| 5582T | Oncotaxel 80, GN – Docetaxel, docetaxel 80 mg/4 mL injection, 1 x 4 mL vial | TA | GN |
| Oncotaxel 140, GN – Docetaxel, docetaxel 140 mg/7 mL injection, 1 x 7 mL vial | TA | GN | |
| 5583W | Oncotaxel 80, GN – Docetaxel, docetaxel 80 mg/4 mL injection, 1 x 4 mL vial | TA | GN |
| Oncotaxel 140, GN – Docetaxel, docetaxel 140 mg/7 mL injection, 1 x 7 mL vial | TA | GN | |
| 5584X | Oncotaxel 80, GN – Docetaxel, docetaxel 80 mg/4 mL injection, 1 x 4 mL vial | TA | GN |
| Oncotaxel 140, GN – Docetaxel, docetaxel 140 mg/7 mL injection, 1 x 7 mL vial | TA | GN | |
| 7231N | Epirubicin Actavis 10, UA – Epirubicin, epirubicin hydrochloride 10 mg/5 mL injection, 1 x 5 mL vial | TA | UA |
| Epirubicin Actavis 20, UA – Epirubicin, epirubicin hydrochloride 20 mg/10 mL injection, 1 x 10 mL vial | TA | UA | |
| Epirubicin Actavis 50, UA – Epirubicin, epirubicin hydrochloride 50 mg/25 mL injection, 1 x 25 mL vial | TA | UA | |
| Epirubicin Actavis 200, UA – Epirubicin, epirubicin hydrochloride 200 mg/100 mL injection, 1 x 100 mL vial | TA | UA | |
| 4375G | Epirubicin Actavis 10, UA – Epirubicin, epirubicin hydrochloride 10 mg/5 mL injection, 1 x 5 mL vial | TA | UA |
| Epirubicin Actavis 20, UA – Epirubicin, epirubicin hydrochloride 20 mg/10 mL injection, 1 x 10 mL vial | TA | UA | |
| Epirubicin Actavis 50, UA – Epirubicin, epirubicin hydrochloride 50 mg/25 mL injection, 1 x 25 mL vial | TA | UA | |
| Epirubicin Actavis 200, UA – Epirubicin, epirubicin hydrochloride 200 mg/100 mL injection, 1 x 100 mL vial | TA | UA | |
| 7233Q | Fludarabine Actavis, UA – Fludarabine, fludarabine phosphate 50 mg injection, 1 x 50 mg vial | TA | UA |
| 4393F | Fludarabine Actavis, UA – Fludarabine, fludarabine phosphate 50 mg injection, 1 x 50 mg vial | TA | UA |
| 4451G | Irinotecan Actavis, UA – Irinotecan, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 1 x 5 mL vial | TA | UA |
| Irinotecan Actavis 500, UA – Irinotecan, irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 1 x 25 mL vial | TA | UA | |
| 7249M | Irinotecan Actavis, UA – Irinotecan, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 1 x 5 mL vial | TA | UA |
| Irinotecan Actavis 500, UA – Irinotecan, irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 1 x 25 mL vial | TA | UA | |
| 7253R | Oxaliplatin Actavis, UA – Oxaliplatin, oxaliplatin 100 mg injection, 1 x 100 mg vial | TA | UA |
| Oxaliplatin Actavis, UA – Oxaliplatin, oxaliplatin 50 mg injection, 1 x 50 mg vial | TA | UA | |
| 4542C | Oxaliplatin Actavis, UA – Oxaliplatin, oxaliplatin 100 mg injection, 1 x 100 mg vial | TA | UA |
| Oxaliplatin Actavis, UA – Oxaliplatin, oxaliplatin 50 mg injection, 1 x 50 mg vial | TA | UA | |
| 4567J | Paclitaxel Actavis, UA – Paclitaxel, paclitaxel 100 mg/16.7 mL injection, 1 x 16.7 mL vial | TA | UA |
| Paclitaxel Actavis, UA – Paclitaxel, paclitaxel 300 mg/50 mL injection, 1 x 50 mL vial | TA | UA | |
| Paclitaxel Actavis, UA – Paclitaxel, paclitaxel 30 mg/5 mL injection, 1 x 5 mL vial | TA | UA | |
| Paclitaxel Actavis, UA – Paclitaxel, paclitaxel 150 mg/25 mL injection, 1 x 25 mL vial | TA | UA | |
| 7254T | Paclitaxel Actavis, UA – Paclitaxel, paclitaxel 300 mg/50 mL injection, 1 x 50 mL vial | TA | UA |
| Paclitaxel Actavis, UA – Paclitaxel, paclitaxel 100 mg/16.7 mL injection, 1 x 16.7 mL vial | TA | UA | |
| Paclitaxel Actavis, UA – Paclitaxel, paclitaxel 150 mg/25 mL injection, 1 x 25 mL vial | TA | UA | |
| Paclitaxel Actavis, UA – Paclitaxel, paclitaxel 30 mg/5 mL injection, 1 x 5 mL vial | TA | UA |
Advance Notices – Deletion of Brand
The following brands will be deleted from the Schedule of Pharmaceutical Benefits on 1 September 2014:
| 4439P | Gemcitabine Ebewe, SZ – Gemcitabine, gemcitabine 200 mg/5 mL injection, 1 x 5 mL vial |
| Gemcitabine Ebewe, SZ – Gemcitabine, gemcitabine 1 g/25 mL injection, 1 x 25 mL vial | |
| Gemcitabine Ebewe, SZ – Gemcitabine, gemcitabine 2 g/50 mL injection, 1 x 50 mL vial | |
| 7246J | Gemcitabine Ebewe, SZ – Gemcitabine, gemcitabine 200 mg/5 mL injection, 1 x 5 mL vial |
| Gemcitabine Ebewe, SZ – Gemcitabine, gemcitabine 1 g/25 mL injection, 1 x 25 mL vial | |
| Gemcitabine Ebewe, SZ – Gemcitabine, gemcitabine 2 g/50 mL injection, 1 x 50 mL vial |
Repatriation Schedule of Pharmaceutical Benefits (RPBS)
Deletion – Item
| 4579B | Alprostadil, alprostadil 10 microgram injection [2 x 10 microgram syringes] (&) inert substance diluent [2 x 0.6 mL syringes], 1 pack (Caverject Impulse) |
| 4580C | Alprostadil, alprostadil 20 microgram injection [2 x 20 microgram syringes] (&) inert substance diluent [2 x 0.6 mL syringes], 1 pack (Caverject Impulse) |
| 4543D | Sunscreens, SUNSCREENS Solid stick 4.5 g, 1 (Hamilton Solastick 30+) |
Alteration – Manufacturer's Code
| From: | To: | ||
|---|---|---|---|
| 4549K | Hamilton Skin Therapy Wash, KY – Paraffin Light Liquid + Cocoamphodiacetate Disodium, paraffin light liquid 3.5% (35 mg/mL) + cocoamphodiacetate disodium 3% (30 mg/mL) lotion, 500 mL | VT | KY |
| 4546G | Hamilton Sunscreen Family Sunscreen Milk SPF 15, KY – Sunscreens, SUNSCREENS Lotion (non-alcoholic) 125 mL, 1 | VT | KY |
| 4122Y | Hamilton Skin Therapy Oil, KY – Skin Emollient, SKIN EMOLLIENT Bath oil 500 mL, 1 | VT | KY |